• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Decreased levels of serum Angiotensin-(1-7) in patients with pulmonary arterial hypertension due to congenital heart disease.

作者信息

Dai Hailong, Gong Yongfei, Xiao Zhicheng, Guang Xuefeng, Yin Xiaolong

机构信息

Department of Cardiology, Yan'an Affiliated Hospital of Kunming Medical University, Yunnan Cardiovascular Hospital, Kunming, PR China; Institute of Molecular and Clinical Medicine, Kunming Medical University, Kunming, PR China; Department of Anatomy and Developmental Biology, Monash University, Clayton, Australia.

Department of Cardiology, Yan'an Affiliated Hospital of Kunming Medical University, Yunnan Cardiovascular Hospital, Kunming, PR China.

出版信息

Int J Cardiol. 2014 Oct 20;176(3):1399-401. doi: 10.1016/j.ijcard.2014.08.021. Epub 2014 Aug 8.

DOI:10.1016/j.ijcard.2014.08.021
PMID:25150487
Abstract
摘要

相似文献

1
Decreased levels of serum Angiotensin-(1-7) in patients with pulmonary arterial hypertension due to congenital heart disease.先天性心脏病所致肺动脉高压患者血清血管紧张素 -（1 - 7）水平降低。
Int J Cardiol. 2014 Oct 20;176(3):1399-401. doi: 10.1016/j.ijcard.2014.08.021. Epub 2014 Aug 8.
2
Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.先天性心脏病合并肺动脉高压与循环内皮细胞及内皮素-1的相关性
Int J Clin Exp Pathol. 2015 Sep 1;8(9):10743-51. eCollection 2015.
3
Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects.递增剂量西地那非对患有肺动脉高压和先天性心脏缺陷儿童的血流动力学和气体交换的影响。
J Cardiothorac Vasc Anesth. 2007 Apr;21(2):203-7. doi: 10.1053/j.jvca.2006.02.010. Epub 2006 May 18.
4
The changes of serum angiotensin-converting enzyme 2 in patients with pulmonary arterial hypertension due to congenital heart disease.先天性心脏病所致肺动脉高压患者血清血管紧张素转换酶2的变化
Cardiology. 2013;124(4):208-12. doi: 10.1159/000346884. Epub 2013 Mar 20.
5
Elevated serum HMGB1 in pulmonary arterial hypertension secondary to congenital heart disease.先天性心脏病继发肺动脉高压患者血清高迁移率族蛋白B1升高。
Vascul Pharmacol. 2016 Oct;85:66-72. doi: 10.1016/j.vph.2016.08.009. Epub 2016 Aug 24.
6
Atrial natriuretic peptide and nitric oxide in children with pulmonary hypertension after surgical repair of congenital heart disease.先天性心脏病手术修复后肺动脉高压患儿的心房利钠肽和一氧化氮
Am J Cardiol. 1996 Jan 1;77(1):102-5. doi: 10.1016/s0002-9149(97)89147-3.
7
Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.特发性肺动脉高压和先天性心脏病相关肺动脉高压患儿的肺动脉顺应性：与肺血管阻力、运动能力和生存的关系。
Am Heart J. 2011 Sep;162(3):562-8. doi: 10.1016/j.ahj.2011.06.014. Epub 2011 Aug 11.
8
[THE SYSTEM OF SEROTONIN AND ITS METABOLISM IN PLATELETS IN CHILDREN WITH CONGENITAL HEART DEFECTS OF AN EARLY AGE].[幼儿先天性心脏病患儿血小板中血清素系统及其代谢]
Georgian Med News. 2020 Jan(298):42-46.
9
Patients with pulmonary hypertension related to congenital systemic-to-pulmonary shunts are characterized by inflammation involving endothelial cell activation and platelet-mediated inflammation.与先天性体-肺分流相关的肺动脉高压患者的特征是炎症，包括内皮细胞活化和血小板介导的炎症。
Congenit Heart Dis. 2009 May-Jun;4(3):153-9. doi: 10.1111/j.1747-0803.2009.00297.x.
10
Elevated levels of plasma endothelin-1 in young patients with pulmonary hypertension caused by congenital heart disease are decreased after successful surgical repair.先天性心脏病所致肺动脉高压的年轻患者血浆内皮素-1水平升高，成功手术修复后该水平降低。
J Thorac Cardiovasc Surg. 1995 Jul;110(1):271-3. doi: 10.1016/S0022-5223(05)80036-4.

引用本文的文献

1
Ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension mediated by neural precursor cell-expressed developmentally down-regulated gene 4-Like.血管紧张素转换酶 2 的泛素化有助于神经前体细胞表达发育下调基因 4 样物介导的肺动脉高压的发展。
Respir Res. 2024 Aug 29;25(1):326. doi: 10.1186/s12931-024-02953-5.
2
Unique Pulmonary Hypertension in Young Children: A Case Series Study.幼儿特发性肺动脉高压：病例系列研究
Children (Basel). 2022 Jul 17;9(7):1064. doi: 10.3390/children9071064.
3
Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19.
各种缺氧条件下的替代 RAS：从心肌梗死到 COVID-19。
Int J Mol Sci. 2021 Nov 26;22(23):12800. doi: 10.3390/ijms222312800.
4
Angiotensin-Converting Enzyme 2 Activator Ameliorates Severe Pulmonary Hypertension in a Rat Model of Left Pneumonectomy Combined With VEGF Inhibition.血管紧张素转换酶2激活剂改善左肺切除联合血管内皮生长因子抑制大鼠模型中的重度肺动脉高压
Front Med (Lausanne). 2021 Feb 19;8:619133. doi: 10.3389/fmed.2021.619133. eCollection 2021.
5
COVID-19 and the pulmonary vascular injury.新型冠状病毒肺炎与肺血管损伤
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972276. doi: 10.1177/1470320320972276.
6
The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.血管紧张素转化酶 2（ACE2）激活剂对左心功能障碍性肺动脉高压的有益作用。
Int J Med Sci. 2020 Sep 16;17(16):2594-2602. doi: 10.7150/ijms.48096. eCollection 2020.
7
Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost.靶向 Neprilysin（NEP）通路：战胜 COVID-19 幽灵的新希望。
Biochem Pharmacol. 2020 Aug;178:114057. doi: 10.1016/j.bcp.2020.114057. Epub 2020 May 27.
8
Emerging therapeutics in pulmonary hypertension.肺动脉高压的新兴治疗方法。
Am J Physiol Lung Cell Mol Physiol. 2018 May 1;314(5):L769-L781. doi: 10.1152/ajplung.00259.2017. Epub 2018 Feb 1.
9
The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).肾素-血管紧张素系统的 ACE2/血管紧张素-(1-7)/MAS 轴：关注血管紧张素-(1-7)。
Physiol Rev. 2018 Jan 1;98(1):505-553. doi: 10.1152/physrev.00023.2016.
10
ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy.血管紧张素转换酶2与微生物群：心肺疾病治疗的新兴靶点
J Cardiovasc Pharmacol. 2015 Dec;66(6):540-50. doi: 10.1097/FJC.0000000000000307.